HealthEquity (HQY) Reiterated at Market Outperform by Citizens: Q2 Revenue Above Estimate
Tweet Send to a Friend
Citizens analyst Constantine Davides reiterated a Market Outperform rating and $111.00 price target on HealthEquity, Inc (NASDAQ: HQY).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
